Oncogene – celebrates 20 years of shaping the scientific community and publishing the latest developments in cancer research. Oncogene is published weekly and covers the structure and function of oncogenes. Oncogene publishes several review issues annually – Oncogene Reviews takes a closer look into the advances that are impacting the study of cancer.
Free online issue
Volume 27, No 53
13 November 2008
ISSN: 0950-9232
EISSN: 1476-5594
2007 impact factor 6.44*
14/132 Oncology
14/132 Genetics & Heredity
26/156 Cell Biology
32/263 Biochemistry & Molecular Biology
Editors:
J Jenkins
E P Reddy
* Journal Citation Reports, Thomson Reuters, 2008
FEATURED ARTICLES
ORIGINAL ARTICLE
14-3-3
and p21 in p14ARF-induced cell cycle arrest and apoptosis
FREE SHORT COMMUNICATION
BRCA1 modulates UPR signaling FREEORIGINAL ARTICLE
Interactions of IgH enhancers with bcl-2 promoter FREEORIGINAL ARTICLE
COX-2 and POX's inhibition of tumor growthORIGINAL ARTICLE
Monocytic differentiation of MLL-AML by C/EBPsORIGINAL ARTICLE
DNA-PKcs and ATM influence bystander signalingOncogene News
Harmful BMP's. Bone morphogenetic protein (BMP) signaling make breast cancer patients more prone to bone metastasis. Read about Smad pathways role in cell signal causing greater skeletal deformities.
Submit your paper to Nature Precedings. while your manuscript is under consideration. This archive provides a rapid way to disseminate emerging results and new theories, solicit opinions, and record the provenance of ideas. Register to submit documents now.
Oncogene Reviews
PTEN's dynamic users guide. Mechanizing apoptosis is one of many possible future applications involving PTEN. The genes manipulative abilities help to chart out its true role in tumor suppression and genome stability. Read this special reviews issue that showcases PTEN branching involvement in the physiology, pharmacology and genetics of cancer.
Apoptosis reviews series. Read articles on FLIP, Bcl-2 and caspase-independent cell death in this special two-part reviews issue covering the intrinsic and extrinsic pathways of apoptosis.
Other NPG news
Gene therapy for prostate cancer. Prostate cancer affects one in six men and is the second leading cause of cancer death among men in the US. Gene therapy shows promise as a treatment strategy that can target both localized and metastatic prostate cancer. View this web focus to read more about the field of prostate cancer gene therapy.
-
Research and Reviews
Latest research highlights and reviews from the NPG family of journals
- Optically mediated particle clearing using Airy wavepackets Source: Nature Photonics
- Central blood pressure measurement may improve risk stratification - this content is FREE Source: Journal of Human Hypertension
- Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis - this content is FREE Source: Nature Clinical Practice Neurology

